Iron supplementation for restless legs syndrome - A systematic review and meta-analysis.

[1]  W. Oertel,et al.  Treatment of restless legs syndrome: Evidence‐based review and implications for clinical practice (Revised 2017) § , 2018, Movement disorders : official journal of the Movement Disorder Society.

[2]  Y. Cho,et al.  Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs Syndrome. , 2017, Sleep medicine.

[3]  J. Connor,et al.  Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. , 2018, Sleep medicine.

[4]  W. Oertel,et al.  Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial , 2017, Movement disorders : official journal of the Movement Disorder Society.

[5]  Q. Jia,et al.  Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[6]  Ravi Gupta,et al.  A double-blind, randomized, controlled trial to compare the efficacy and tolerability of fixed doses of ropinirole, bupropion, and iron in treatment of restless legs syndrome (Willis–Ekbom disease) , 2016, Annals of Indian Academy of Neurology.

[7]  Y. Cho,et al.  Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome. , 2016, Sleep medicine.

[8]  L. Leibovici,et al.  The safety of intravenous iron preparations: systematic review and meta-analysis. , 2015, Mayo Clinic proceedings.

[9]  A. Walters,et al.  Review of diagnostic instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendations. , 2014, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[10]  J. Winkelmann,et al.  Iron in Restless Legs Syndrome , 2014, Movement disorders clinical practice.

[11]  A. Walters,et al.  Review of quality of life instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendations. , 2014, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[12]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[13]  C. Adler,et al.  Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial. , 2011, Sleep medicine.

[14]  G. Birgegard,et al.  High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron , 2010, Vox sanguinis.

[15]  V. Mysliwiec,et al.  Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study. , 2009, Sleep medicine.

[16]  J. Hedner,et al.  A randomized, double‐blind, placebo controlled, multi‐center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome , 2009, Movement disorders : official journal of the Movement Disorder Society.

[17]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[18]  P. Barker,et al.  A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. , 2009, Sleep medicine.

[19]  A. Feigin,et al.  A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  Christopher J. Earley,et al.  Restless legs syndrome , 2003, Current treatment options in neurology.

[21]  Richard P Allen,et al.  Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. , 2003, Sleep medicine.

[22]  C. Earley.  Clinical practice. Restless legs syndrome. , 2003, The New England journal of medicine.

[23]  A. Rajput,et al.  A Randomized, Double-Blind Placebo-Controlled Trial of Iron in Restless Legs Syndrome , 2000, European Neurology.

[24]  K. Ekbom.  Restless legs syndrome , 1960, Neurology.